Press releases

Boston Scientific Corporation (NYSE: BSX) today announced that Ken Stein, M.D., FACC, will join the Company as Senior Vice President and Associate...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European...

The statement below is from Pete Nicholas, Chairman of the Board of Boston Scientific Corporation, on behalf of the Company, its employees and its Board of...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing final results from the landmark MADIT-CRT trial on Tuesday,...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets 9(th) Annual Focus on Health Care Conference, August 5.

Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Katharine T. Bartlett and Bruce L....

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2009, as well as guidance for net...

Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark for its LATITUDE® Patient Management system. The LATITUDE system remotely...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2009...

Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer (CEO) Jim Tobin will retire from the Company,...

Landmark trial shows Boston Scientific CRT-Ds slow the progression of heart failure in asymptomatic and mildly symptomatic patients NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wachovia 19th Annual Mid-Year Equity Conference, June 23 - 24. Jim...

Boston Scientific Corporation (NYSE: BSX) today announced that results from nine studies involving the Company's Urology/Gynecology products will...

Studies to be presented on safety and efficacy of SpyGlass System for diagnostic and therapeutic procedures throughout pancreatico-biliary system NATICK, Mass., May 28 /PRNewswire-FirstCall/ --...

SpyGlass® Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific...

Boston Scientific Corporation (NYSE: BSX) today announced that Ursula Burns and Kristina Johnson have resigned from the Company's Board of Directors...

Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...

Risk of death at five years is lower for aneurysm patients treated with coil embolization compared to surgical clipping NATICK, Mass., May 26 /PRNewswire-FirstCall/ -- Boston Scientific...

Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the ORION clinical trial, which is designed to evaluate...

Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of economic and quality of life outcomes,...

Boston Scientific Corporation (NYSE: BSX) today announced that Fitch Ratings has raised the Company's rating outlook to positive from stable, while...

Boston Scientific Corporation (NYSE: BSX) today announced positive outcomes from a substudy of patients with left main coronary...

Boston Scientific Corporation (NYSE: BSX) today announced the launch of the...

Online tools will help physicians determine treatment strategies NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the...